Cargando…
Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults
Smallpox vaccination may confer cross-protection to mpox. We evaluated vaccinia virus antibodies in 162 persons ≥50 years of age in Spain; 68.5% had detectable antibodies. Highest coverage (78%) was among persons 71–80 years of age. Low antibody levels in 31.5% of this population indicates that addr...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973709/ https://www.ncbi.nlm.nih.gov/pubmed/36732061 http://dx.doi.org/10.3201/eid2903.221231 |
| _version_ | 1784898588660203520 |
|---|---|
| author | Sanz-Muñoz, Iván Sánchez-dePrada, Laura Sánchez-Martínez, Javier Rojo-Rello, Silvia Domínguez-Gil, Marta Hernán-García, Cristina Fernández-Espinilla, Virginia de Lejarazu-Leonardo, Raúl Ortiz Castrodeza-Sanz, Javier Eiros, José María |
| author_facet | Sanz-Muñoz, Iván Sánchez-dePrada, Laura Sánchez-Martínez, Javier Rojo-Rello, Silvia Domínguez-Gil, Marta Hernán-García, Cristina Fernández-Espinilla, Virginia de Lejarazu-Leonardo, Raúl Ortiz Castrodeza-Sanz, Javier Eiros, José María |
| author_sort | Sanz-Muñoz, Iván |
| collection | PubMed |
| description | Smallpox vaccination may confer cross-protection to mpox. We evaluated vaccinia virus antibodies in 162 persons ≥50 years of age in Spain; 68.5% had detectable antibodies. Highest coverage (78%) was among persons 71–80 years of age. Low antibody levels in 31.5% of this population indicates that addressing their vaccination should be a priority. |
| format | Online Article Text |
| id | pubmed-9973709 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99737092023-03-01 Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults Sanz-Muñoz, Iván Sánchez-dePrada, Laura Sánchez-Martínez, Javier Rojo-Rello, Silvia Domínguez-Gil, Marta Hernán-García, Cristina Fernández-Espinilla, Virginia de Lejarazu-Leonardo, Raúl Ortiz Castrodeza-Sanz, Javier Eiros, José María Emerg Infect Dis Research Letter Smallpox vaccination may confer cross-protection to mpox. We evaluated vaccinia virus antibodies in 162 persons ≥50 years of age in Spain; 68.5% had detectable antibodies. Highest coverage (78%) was among persons 71–80 years of age. Low antibody levels in 31.5% of this population indicates that addressing their vaccination should be a priority. Centers for Disease Control and Prevention 2023-03 /pmc/articles/PMC9973709/ /pubmed/36732061 http://dx.doi.org/10.3201/eid2903.221231 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
| spellingShingle | Research Letter Sanz-Muñoz, Iván Sánchez-dePrada, Laura Sánchez-Martínez, Javier Rojo-Rello, Silvia Domínguez-Gil, Marta Hernán-García, Cristina Fernández-Espinilla, Virginia de Lejarazu-Leonardo, Raúl Ortiz Castrodeza-Sanz, Javier Eiros, José María Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults |
| title | Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults |
| title_full | Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults |
| title_fullStr | Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults |
| title_full_unstemmed | Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults |
| title_short | Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults |
| title_sort | possible mpox protection from smallpox vaccine–generated antibodies among older adults |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973709/ https://www.ncbi.nlm.nih.gov/pubmed/36732061 http://dx.doi.org/10.3201/eid2903.221231 |
| work_keys_str_mv | AT sanzmunozivan possiblempoxprotectionfromsmallpoxvaccinegeneratedantibodiesamongolderadults AT sanchezdepradalaura possiblempoxprotectionfromsmallpoxvaccinegeneratedantibodiesamongolderadults AT sanchezmartinezjavier possiblempoxprotectionfromsmallpoxvaccinegeneratedantibodiesamongolderadults AT rojorellosilvia possiblempoxprotectionfromsmallpoxvaccinegeneratedantibodiesamongolderadults AT dominguezgilmarta possiblempoxprotectionfromsmallpoxvaccinegeneratedantibodiesamongolderadults AT hernangarciacristina possiblempoxprotectionfromsmallpoxvaccinegeneratedantibodiesamongolderadults AT fernandezespinillavirginia possiblempoxprotectionfromsmallpoxvaccinegeneratedantibodiesamongolderadults AT delejarazuleonardoraulortiz possiblempoxprotectionfromsmallpoxvaccinegeneratedantibodiesamongolderadults AT castrodezasanzjavier possiblempoxprotectionfromsmallpoxvaccinegeneratedantibodiesamongolderadults AT eirosjosemaria possiblempoxprotectionfromsmallpoxvaccinegeneratedantibodiesamongolderadults |